These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 22287651

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
    Tang Y, Dundamadappa SK, Thangasamy S, Flood T, Moser R, Smith T, Cauley K, Takhtani D.
    AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. S100A5: a marker of recurrence in WHO grade I meningiomas.
    Hancq S, Salmon I, Brotchi J, De Witte O, Gabius HJ, Heizmann CW, Kiss R, Decaestecker C.
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Meningiomas: correlation of Ki67 with histological grade.
    Babu S, Uppin SG, Uppin MS, Panigrahi MK, Saradhi V, Bhattacharjee S, Sahu BP, Purohit AK, Challa S.
    Neurol India; 2011 Apr; 59(2):204-7. PubMed ID: 21483118
    [Abstract] [Full Text] [Related]

  • 27. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].
    Hernández Faraco A, Céspedes G, Trejo E.
    Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293
    [Abstract] [Full Text] [Related]

  • 28. Characterization of morphologically benign biologically aggressive meningiomas.
    Rao S, Sadiya N, Doraiswami S, Prathiba D.
    Neurol India; 2009 May; 57(6):744-8. PubMed ID: 20139503
    [Abstract] [Full Text] [Related]

  • 29. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
    Kärjä V, Sandell PJ, Kauppinen T, Alafuzoff I.
    Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Caveolin-1 in meningiomas: expression and clinico-pathological correlations.
    Barresi V, Cerasoli S, Paioli G, Vitarelli E, Giuffrè G, Guiducci G, Tuccari G, Barresi G.
    Acta Neuropathol; 2006 Nov; 112(5):617-26. PubMed ID: 16850311
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The expression of fatty acid metabolism-associated proteins is correlated with the prognosis of meningiomas.
    Jiang J, Lin C, Liu N, Zhang Z, Sun Y, Fang X, Qi J.
    APMIS; 2013 Oct; 121(10):997-1003. PubMed ID: 23879478
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Meningiomas: new prognostic factors].
    Sanz Esponera J.
    An R Acad Nac Med (Madr); 2007 Oct; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.